CVA Family Office’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$477	Buy	18 +3	+20%	+$80	﹤0.01%	1246
2025 Q1	$362	Buy	+15	New	+$362	﹤0.01%	1364
2024 Q4	–	Sell	-10	Closed	-$633	–	1343
2024 Q3	$633	Buy	+10	New	+$633	﹤0.01%	1144